EC10/IC10 values and EC50/IC50 values (μM) of compounds showing agonism or antagonism toward the ER.
. | ER agonism . | ER antagonism . | ||||||
---|---|---|---|---|---|---|---|---|
. | EC10 . | 95% CI of EC10 . | EC50 . | 95% CI of EC50 . | IC10 . | 95% CI of IC10 . | IC50 . | 95% CI of IC50 . |
E2 | 7.4 × 10−7 | 4.9 × 10−7, 1.1 × 10−6 | 3.7 × 10−6 | 2.9 × 10−6, 4.5 × 10−6 | ||||
ICI-182.780 | 6.0 × 10−6 | 4.9 × 10−6 to 7.4 × 10−6 | 2.8 × 10−5 | 2.5 × 10−5 to 3.0 × 10−5 | ||||
Ametryn | 30.9 | 24.8 to 38.2 | 108 | 99.5 to 119 | ||||
Bitertanol | 0.53 | 0.2 to 1.3 | 9.3 | 6.2 to 14.7 | ||||
Fenbuconazole | 6.9 | 5.5 to 8.6 | 24.0 | 21.9 to 26.4 | ||||
Tebuconazole | 16.6 | 12.1 to 23.2 | 45.4 | 37.8 to 54.8 | ||||
Cyproconazole | 26.4 | 11.6 to 46.9 | 227 | 140 to 650 | ||||
Difenoconazole | 0.55 | 0.33 to 0.94 | 2.2 | 1.7 to 2.8 | ||||
Propiconazole | 9.6 | 6.0 to 15.5 | 36.0 | 28.5 to 45.7 | ||||
Paclobutrazol | 13.6 | 8.5 to 21.2 | 84.5 | 68.7 to 109 | ||||
Triadimenol | 3.4 | 0.65 to 12.6 | 128 | 56.8 to 880 |
. | ER agonism . | ER antagonism . | ||||||
---|---|---|---|---|---|---|---|---|
. | EC10 . | 95% CI of EC10 . | EC50 . | 95% CI of EC50 . | IC10 . | 95% CI of IC10 . | IC50 . | 95% CI of IC50 . |
E2 | 7.4 × 10−7 | 4.9 × 10−7, 1.1 × 10−6 | 3.7 × 10−6 | 2.9 × 10−6, 4.5 × 10−6 | ||||
ICI-182.780 | 6.0 × 10−6 | 4.9 × 10−6 to 7.4 × 10−6 | 2.8 × 10−5 | 2.5 × 10−5 to 3.0 × 10−5 | ||||
Ametryn | 30.9 | 24.8 to 38.2 | 108 | 99.5 to 119 | ||||
Bitertanol | 0.53 | 0.2 to 1.3 | 9.3 | 6.2 to 14.7 | ||||
Fenbuconazole | 6.9 | 5.5 to 8.6 | 24.0 | 21.9 to 26.4 | ||||
Tebuconazole | 16.6 | 12.1 to 23.2 | 45.4 | 37.8 to 54.8 | ||||
Cyproconazole | 26.4 | 11.6 to 46.9 | 227 | 140 to 650 | ||||
Difenoconazole | 0.55 | 0.33 to 0.94 | 2.2 | 1.7 to 2.8 | ||||
Propiconazole | 9.6 | 6.0 to 15.5 | 36.0 | 28.5 to 45.7 | ||||
Paclobutrazol | 13.6 | 8.5 to 21.2 | 84.5 | 68.7 to 109 | ||||
Triadimenol | 3.4 | 0.65 to 12.6 | 128 | 56.8 to 880 |
EC10/IC10 values and EC50/IC50 values (μM) of compounds showing agonism or antagonism toward the ER.
. | ER agonism . | ER antagonism . | ||||||
---|---|---|---|---|---|---|---|---|
. | EC10 . | 95% CI of EC10 . | EC50 . | 95% CI of EC50 . | IC10 . | 95% CI of IC10 . | IC50 . | 95% CI of IC50 . |
E2 | 7.4 × 10−7 | 4.9 × 10−7, 1.1 × 10−6 | 3.7 × 10−6 | 2.9 × 10−6, 4.5 × 10−6 | ||||
ICI-182.780 | 6.0 × 10−6 | 4.9 × 10−6 to 7.4 × 10−6 | 2.8 × 10−5 | 2.5 × 10−5 to 3.0 × 10−5 | ||||
Ametryn | 30.9 | 24.8 to 38.2 | 108 | 99.5 to 119 | ||||
Bitertanol | 0.53 | 0.2 to 1.3 | 9.3 | 6.2 to 14.7 | ||||
Fenbuconazole | 6.9 | 5.5 to 8.6 | 24.0 | 21.9 to 26.4 | ||||
Tebuconazole | 16.6 | 12.1 to 23.2 | 45.4 | 37.8 to 54.8 | ||||
Cyproconazole | 26.4 | 11.6 to 46.9 | 227 | 140 to 650 | ||||
Difenoconazole | 0.55 | 0.33 to 0.94 | 2.2 | 1.7 to 2.8 | ||||
Propiconazole | 9.6 | 6.0 to 15.5 | 36.0 | 28.5 to 45.7 | ||||
Paclobutrazol | 13.6 | 8.5 to 21.2 | 84.5 | 68.7 to 109 | ||||
Triadimenol | 3.4 | 0.65 to 12.6 | 128 | 56.8 to 880 |
. | ER agonism . | ER antagonism . | ||||||
---|---|---|---|---|---|---|---|---|
. | EC10 . | 95% CI of EC10 . | EC50 . | 95% CI of EC50 . | IC10 . | 95% CI of IC10 . | IC50 . | 95% CI of IC50 . |
E2 | 7.4 × 10−7 | 4.9 × 10−7, 1.1 × 10−6 | 3.7 × 10−6 | 2.9 × 10−6, 4.5 × 10−6 | ||||
ICI-182.780 | 6.0 × 10−6 | 4.9 × 10−6 to 7.4 × 10−6 | 2.8 × 10−5 | 2.5 × 10−5 to 3.0 × 10−5 | ||||
Ametryn | 30.9 | 24.8 to 38.2 | 108 | 99.5 to 119 | ||||
Bitertanol | 0.53 | 0.2 to 1.3 | 9.3 | 6.2 to 14.7 | ||||
Fenbuconazole | 6.9 | 5.5 to 8.6 | 24.0 | 21.9 to 26.4 | ||||
Tebuconazole | 16.6 | 12.1 to 23.2 | 45.4 | 37.8 to 54.8 | ||||
Cyproconazole | 26.4 | 11.6 to 46.9 | 227 | 140 to 650 | ||||
Difenoconazole | 0.55 | 0.33 to 0.94 | 2.2 | 1.7 to 2.8 | ||||
Propiconazole | 9.6 | 6.0 to 15.5 | 36.0 | 28.5 to 45.7 | ||||
Paclobutrazol | 13.6 | 8.5 to 21.2 | 84.5 | 68.7 to 109 | ||||
Triadimenol | 3.4 | 0.65 to 12.6 | 128 | 56.8 to 880 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.